The reduced expression of MAP1LC3A in mouse NAFLD samples was statistically lower than that of the normal liver samples (Fig. 8B, ***p < 0.0001, p = 0.000005). The gene discussed is MAP1LC3A; the disease is metabolic dysfunction-associated steatotic liver disease.